Cadegiani, F. A. (2020). Can spironolactone be used to prevent COVID-19-induced acute respiratory distress syndrome in patients with hypertension?. American Journal of Physiology-Endocrinology and Metabolism, 318(5), E587-E588. https://doi.org/10.1152/ajpendo.00136.2020